Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 21, 2019 (7 years ago)

Lactulose Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Cause type: Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection. All microbial contamination recalls.

What was recalled

Lactulose Solution, USP 10 g/15 mL, For Oral or Rectal Administration, Rx Only, 16 FL. oz. Bottle, NDC:13668-574-10, Manufactured By Bio-Pharm, Levittown, PA 19057, Manufactured for Torrent Pharma Inc., Basking Ridge, NJ 07920.

Affected NDC 13668-0574-10

Compare with the code on your package — it is the most precise check available.

Drug: Lactulose

Recalling firm
Torrent Pharma Inc
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1373-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Lactulose recalls

See all
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0815-2023
Class II · Moderate risk

Lactulose Solution

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0814-2023
Class II · Moderate risk

Lactulose Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1372-2019
Class II · Moderate risk

Lactulose Solution

Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-038-01 D-1053-2017
Class II · Moderate risk

Lactulose Solution

Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-038-50 D-1052-2017

Other recalls by Torrent Pharma Inc

All 2019 recalls
Class II · Moderate risk

Fluoxetine Tablets

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Completed Nitrosamine impurity Torrent Pharma Inc. D-0456-2025
Class II · Moderate risk

Fluoxetine Tablets

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Completed Nitrosamine impurity Torrent Pharma Inc. D-0455-2025